{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T03:18:17Z","timestamp":1772853497879,"version":"3.50.1"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Interleukin-2 receptor alpha chain (IL2RA, CD25) deficiency is a rare autosomal recessive inborn error of immunity characterized by profound immune dysregulation, susceptibility to infections, and autoimmunity. Only 13 cases of\n                      <jats:italic>IL2RA<\/jats:italic>\n                      deficiency have been reported worldwide since its first description in 1997, and experience with allogeneic hematopoietic stem cell transplantation (HSCT) for this condition remains very limited. This study aimed to describe the clinical, immunological, genetic, and HSCT outcomes of two siblings with\n                      <jats:italic>IL2RA<\/jats:italic>\n                      deficiency with a novel homozygous frameshift mutation and to review previously reported cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The clinical course, laboratory findings, genetic diagnosis, and transplant outcomes of two patients managed at King Faisal Specialist Hospital &amp;amp; Research Centre were retrospectively reviewed. A comprehensive literature review was conducted to contextualize these cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Both patients presented with severe enteropathy, eczema, recurrent respiratory infections, growth failure, and features of allergic disease in early childhood. Immunological evaluation revealed hypergammaglobulinemia, impaired T-cell proliferation, reduced CD19\n                      <jats:sup>+<\/jats:sup>\n                      B cells, inverted CD4\/CD8 ratio, and absence of CD25 expression. Genetic analysis revealed a novel homozygous frameshift variant in\n                      <jats:italic>IL2RA<\/jats:italic>\n                      (c.166delC; p.R56fs). Both patients underwent HSCT with myeloablative conditioning. The younger sibling received marrow from a matched unrelated donor and achieved full donor chimerism with complete clinical and immunological recovery, remaining well 6 years after HSCT. The older sibling received marrow from a matched related donor and is alive and stable at 5 years of follow-up, with sustained donor chimerism and resolution of autoimmunity, complicated only by transient mild chronic graft-versus-host disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      The two cases expand the mutational and clinical spectrum of\n                      <jats:italic>IL2RA<\/jats:italic>\n                      deficiency and provide long-term evidence that HSCT can cure immune dysregulation and susceptibility to infection. The findings underscore the importance of early genetic diagnosis and timely consideration of HSCT as definitive therapy for this rare but life-threatening disorder.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1716101","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:44:54Z","timestamp":1769150694000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Expanding the clinical spectrum of interleukin-2 receptor alpha chain deficiency: two novel cases with long-term hematopoietic stem cell transplantation outcome and literature review"],"prefix":"10.3389","volume":"17","author":[{"given":"Maha","family":"Alzubedy","sequence":"first","affiliation":[{"name":"Section of Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Sayed","family":"Osman","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huda","family":"Alajlan","sequence":"additional","affiliation":[{"name":"Department of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anas M","family":"Alazami","sequence":"additional","affiliation":[{"name":"Department of Translational Genomics, Genomic Medicine Centre of Excellence, King Faisal Specialist Hospital & Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamoud","family":"Al-Mousa","sequence":"additional","affiliation":[{"name":"Section of Allergy and Immunology, Department of Pediatrics, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.7.3168","article-title":"Human immune disorder arising from mutation of the \u03b1 chain of the interleukin-2\u2009receptor","volume":"94","author":"Sharfe","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.immuni.2013.01.004","article-title":"Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.10.007","article-title":"CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked\u2013like syndrome, and defective IL-10 expression from CD4 lymphocytes","volume":"119","author":"Caudy","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2019.02.003","article-title":"CD25 deficiency: a new conformational mutation prevents the receptor expression on cell surface","volume":"201","author":"Vignoli","year":"2019","journal-title":"Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12214","article-title":"Follicular bronchiolitis as phenotype associated with CD25 deficiency","volume":"175","author":"Bezrodnik","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2013.01.004","article-title":"Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity","volume":"146","author":"Goudy","year":"2013","journal-title":"Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0326-5","article-title":"Reprogramming human T cell function and specificity with non-viral genome targeting","volume":"559","author":"Roth","year":"2018","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/20406223221116798","article-title":"Granulomatous hepatitis in a Saudi child with IL2RA defect: a case report and literature review","volume":"13","author":"Alaifan","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/icl.0000000000000346","article-title":"Severe dry eye in CD25 deficiency syndrome","volume":"44","author":"Ba\u015f","year":"2018","journal-title":"Eye Contact Lens"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.09.027","article-title":"Effective and safe treatment of a novel IL2RA deficiency with rapamycin","volume":"8","author":"Lai","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00251-022-01278-1","article-title":"Whole exome sequencing identified a novel splice donor site variant in interleukin 2 receptor alpha chain","volume":"75","author":"Waheed","year":"2023","journal-title":"Immunogenetics"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1310","article-title":"Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases","volume":"137","author":"Al-Mousa","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/mop.0000000000000029","article-title":"Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases","volume":"25","author":"Verbsky","year":"2013","journal-title":"Curr Opin Pediatr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0812851107","article-title":"Competing feedback loops shape IL-2 signaling between helper and regulatory T lymphocytes in cellular microenvironments","volume":"107","author":"Busse","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.14785\/lpsn-2014-0003","article-title":"Pulmonary hemorrhage in a case of CD25 deficiency","volume":"1","author":"Al Sukaiti","year":"2014","journal-title":"LymphoSign J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1716101\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:44:55Z","timestamp":1769150695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1716101\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":15,"alternative-id":["10.3389\/fimmu.2026.1716101"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1716101","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"article-number":"1716101"}}